Improving imaging techniques for liver cancer diagnosis and treatment assessment
Dynamic Nuclear Polarization MR Spectroscopic Imaging for Diagnosis and Treatment Response Assessment in Hepatocellular Carcinoma
['FUNDING_R01'] · UNIVERSITY OF PENNSYLVANIA · NIH-10999408
This study is looking at new imaging techniques to help doctors better diagnose and track the treatment of liver cancer, aiming to provide clearer and more helpful information for patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10999408 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the diagnosis and treatment response evaluation of hepatocellular carcinoma (HCC) using advanced imaging techniques. It aims to develop dynamic nuclear polarization MR spectroscopic imaging, which could provide more accurate and functional insights into HCC biology compared to traditional imaging methods. By addressing the limitations of current imaging paradigms, the research seeks to improve the sensitivity and specificity of HCC detection and treatment monitoring, ultimately leading to better patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with hepatocellular carcinoma who require imaging for diagnosis or treatment assessment.
Not a fit: Patients with liver cancer who are not eligible for imaging or those with other types of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and improved treatment monitoring for patients with liver cancer.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques for cancer diagnosis, suggesting that this approach could lead to significant advancements in the field.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GADE, TERENCE P — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: GADE, TERENCE P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.